Gly101Val Mutation Directly Causes Resistance to Venetoclax

Researchers identified a single heterozygous nucleotide variant that confers resistance to venetoclax, and it's a mutation that may be detected years before clinical relapse occurs.

from Latest articles from Cancer Therapy Advisor Hematologic Cancers https://ift.tt/2EfsL7u